LivaNova Commences Global RESTORE-LIFE Study for Treatment Resistant Depression

Livanova PLC has announced the launch and enrollment of the first patient for its observational post-market study to assess the effectiveness of its Vagus Nerve Stimulation Therapy.  The study will assess the short, medium and long term impact of ‘VNS Therapy’ on those suffering from treatment resistant depression.  Read the article here.

Print Friendly, PDF & Email

Subscribe to LWD

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 1,811 other subscribers

Leave a Reply

Your email address will not be published. Required fields are marked *

Name *

Built by Staple Creative

%d bloggers like this: